البحوث
| 2024 | oncology and radiotherapy | |
|---|---|---|
| remifentanil is prefered over labetalol in case of inducing hypotension because less side effect | ||
| 2024 | oncology and radiotherapy | |
|---|---|---|
| remifentanil is prefered over labetalol in case of inducing hypotension because less side effect | ||